We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
376
Hilton Worldwide
HLT
$73.7B
$63.6K ﹤0.01%
+209
New +$63.4K
DNLI icon
377
Denali Therapeutics
DNLI
$3.78B
$63.2K ﹤0.01%
3,294
+413
+14% +$8.22K
TNGX icon
378
Tango Therapeutics
TNGX
$4.72B
$63K ﹤0.01%
3,011
+365
+14% +$5.08K
TVTX icon
379
Travere Therapeutics
TVTX
$5.26B
$59.7K ﹤0.01%
2,009
+252
+14% +$7.53K
DYN icon
380
Dyne Therapeutics
DYN
$3.94B
$58.2K ﹤0.01%
3,208
+402
+14% +$6.93K
SKT icon
381
Tanger
SKT
$4.82B
$58.1K ﹤0.01%
1,711
-164
-9% -$5.64K
NHI icon
382
National Health Investors
NHI
$3.93B
$58.1K ﹤0.01%
718
-69
-9% -$5.75K
VERA icon
383
Vera Therapeutics
VERA
$2.67B
$57.8K ﹤0.01%
1,436
+180
+14% +$7.75K
EPR icon
384
EPR Properties
EPR
$4.75B
$57.5K ﹤0.01%
1,151
-110
-9% -$6.05K
CUZ icon
385
Cousins Properties
CUZ
$5.24B
$57.3K ﹤0.01%
2,539
-244
-9% -$5.92K
VCYT icon
386
Veracyte
VCYT
$4.75B
$57.2K ﹤0.01%
1,775
+222
+14% +$8.22K
TXG icon
387
10x Genomics
TXG
$5.99B
$55.5K ﹤0.01%
2,616
+328
+14% +$6.56K
BEAM icon
388
Beam Therapeutics
BEAM
$2.81B
$54.3K ﹤0.01%
2,279
+285
+14% +$7.91K
IRON icon
389
Disc Medicine
IRON
$2.89B
$54.2K ﹤0.01%
848
+106
+14% +$7.36K
RDDT icon
390
Reddit
RDDT
$35.8B
$53.5K ﹤0.01%
+397
New +$67.6K
ORKA
391
Oruka Therapeutics
ORKA
$5.69B
$53.3K ﹤0.01%
1,087
+137
+14% +$4.76K
IRT icon
392
Independence Realty Trust
IRT
$3.88B
$52.6K ﹤0.01%
3,535
-339
-9% -$5.57K
ELVN icon
393
Enliven Therapeutics
ELVN
$3.88B
$52.3K ﹤0.01%
1,333
+168
+14% +$4.65K
BNL icon
394
Broadstone Net Lease
BNL
$4.38B
$52.2K ﹤0.01%
2,859
-273
-9% -$5.14K
CDP icon
395
COPT Defense Properties
CDP
$4.26B
$52.2K ﹤0.01%
1,707
-170
-9% -$5.29K
MRP
396
Millrose Properties Inc
MRP
$4.71B
$52.2K ﹤0.01%
1,865
-179
-9% -$5.39K
SRPT icon
397
Sarepta Therapeutics
SRPT
$1.71B
$51K ﹤0.01%
2,343
+284
+14% +$5.5K
PL icon
398
Planet Labs
PL
$8.23B
$49.9K ﹤0.01%
1,786
-4,427
-71% -$113K
COLD icon
399
Americold
COLD
$4.38B
$49.3K ﹤0.01%
4,305
-414
-9% -$5.19K
DAWN
400
DELISTED
Day One Biopharmaceuticals
DAWN
$49.2K ﹤0.01%
2,294
+277
+14% +$3.9K
14 15
16
17 18

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.